Work

Molecular Responses in Newly Diagnosed Chronic Myelocytic Leukemia (CML) Patients Treated with 800 mg Imatinib Daily: An Update from the RIGHT Trial Study Group.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.2149.2149

Authors: Jorge Cortes, Francis Giles, August J. Salvado, Karen McDougall, Jerald Radich, Maher Albitar, Bayard L. Powell, Stuart Goldberg, Hagop M. Kantarjian

Institutions: The University of Texas MD Anderson Cancer Center, Fred Hutch Cancer Center, Quest Diagnostics (United States), Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University Health Sciences, Wake Forest University, Hackensack University Medical Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2570312805

FWCI: 1.627

Cites:

Cited by: 11

Related to: 10